Andrew B. Singleton, PhD
Distinguished Investigator at National Institute on Aging
Location: Bethesda, Maryland, United States
Andrew Singleton, PhD, is an NIH (National Institutes of Health) Distinguished Investigator. He leads a large laboratory comprising about 50 staff members, including five principal investigators and three group leaders, who study the genetic basis of neurological disorders. The goal of this research is to identify genetic variability that causes or contributes to disease and to use this knowledge to understand the molecular processes underlying disease.
Dr. Singleton has published more than 500 articles and serves on the editorial boards of nine scientific journals. He also serves on the scientific advisory boards of The Michael J. Fox Foundation (MJFF) and the Lewy Body Dementia Association (LBDA). Dr. Singleton was awarded the Boehringer Mannheim Research Award in 2005, the NIH Director's Award in 2008 and 2016, the Annemarie Opprecht Award for Parkinson's disease research in 2008, the Jay van Andel Award for Outstanding Achievement in Parkinson's Disease Research in 2012, the American Academy of Neurology Movement Disorders Award and an honorary doctorate from the University of Sunderland in 2017.
- Mapping Genetic and Molecular Networks Linked to Parkinsonís Disease (2018)
- Parkinson's Disease Genetics Sequencing Consortium (2016)
- Whole genome sequencing and analysis of the PPMI prodromal and genetic cohorts, PPMI genetic registry, and the LRRK2 cohort consortium (2015)
- NeuroX profiling of samples from the PPMI prodromal and genetic cohorts, the LRRK2 cohort consortium and the BioFIND cohort (2015)
- Defining Genetic Factors for PD in a Conserved Population (2009)